MCLA-129 is under clinical development by Merus and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer. According to GlobalData, Phase II drugs for Paranasal Sinus And Nasal Cavity ...

Nogapendekin alfa is under clinical development by ImmunityBio and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer. According to GlobalData, Phase II drugs for Paranasal Sinus And ...

Drinking more than four cups of coffee daily has been found to lower the risk of head and neck cancer, a new analysis reveals.

It is relatively rare in the head and neck region, and no standard treatment has been established. Here, we report a case of primary neuroendocrine cancer of the nasal cavity in an elderly adult. This ...

Oral cavity cancer, often referred to as mouth cancer, is a serious health concern that affects hundreds of people globally. With a recent rise in the number of cases reported in India ...

We selected 16 cases of nasal cavity, lung, liver or prostate cancers as typical tumor sites receiving PSPT. The dose distributions and dose volume histograms optimized by the IMPT were compared with ...

Head and neck cancer comprises a group of biologically similar cancers that start in the lip, oral cavity (mouth), nasal cavity (inside the nose), paranasal sinuses, pharynx and larynx.

Microbes that reside peaceably in the nasal passageways and on the skin can be harnessed for taking drugs to target cells.

But in some cases, it may get worse. Rarely if a sinus infection affects a sinus cavity close to the brain, it can spread to the space around the brain. An infection can also pass into the eye ...

PH284 nasal spray increased hunger in cancer cachexia patients, showing a 71% improvement in subjective hunger scores compared to baseline. The phase 2A study demonstrated PH284's safety, with no ...

For example, they excluded participants who had cancer in the salivary glands or nasal cavity. Thus, this study did not look at every subtype that is considered part of head and neck cancer.